Integrum AB (publ) (INTEG-B.ST)

SEK 18.65

(3.04%)

Market Cap (In SEK)

331.88 Million

Revenue (In SEK)

104.11 Million

Net Income (In SEK)

4.03 Million

Avg. Volume

62.78 Thousand

Currency
SEK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
17.4-64.0
PE
-
EPS
-
Beta Value
1.737
ISIN
SE0009807266
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Scott D. Flora
Employee Count
-
Website
https://www.integrum.se
Ipo Date
2017-05-15
Details
Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. The company also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputation. It sells its implant systems to hospitals, clinics, and orthopedists worldwide. The company was founded in 1962 and is headquartered in Mölndal, Sweden.